Ionpath
2 known investors
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
BiotechDeep TechMedical Devices
Investors · 2
In the news
- Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovationbusinesswire.com · 2022
- Ionpath - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Ionpath - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Ionpath Closes $18M Series B Round | GenomeWebgenomeweb.com · 2020